最新文章：伊维菌素和甲苯咪唑治疗案例——一位50岁的内布拉斯加州女性，患有四期三

最新文章：伊维菌素和甲苯咪唑治疗案例——一位50岁的内布拉斯加州女性，患有四期三阴性乳腺癌（TNBC）并已扩散至骨骼，6个月后报告病情进展一些伊维菌素治疗癌症的成功案例非常简单😃故事：一名 50 岁的内布拉斯加州女性，患有 4 期乳腺癌（三阴性乳腺癌），伴有骨转移（自 2022 年 12 月起被诊断为 4 期）。2025年3月初，她开始了：伊维菌素 1mg/kg/天甲苯咪唑 1000 毫克/天肿瘤科医生给她开了卡培他滨3个月后的结果：Signatera归零并保持在零。PET/CT显示多发性骨转移灶有所改善无新的转移灶。一个非常简单的案例。你可以看到，该患者在开始服用伊维菌素和甲苯达唑之前，循环肿瘤 DNA 的 Signatera 检测结果多次出现峰值，从那以后，该值降至零并一直保持在零。这是她的肿瘤科医生在过去三年里都没能做到的。NEW ARTICLE: IVERMECTIN and MEBENDAZOLE Testimonial - 50 year old Nebraska woman with Stage 4 Breast Cancer TNBC to bones, reports after 6 monthsSome Ivermectin Cancer success stories are incredibly simple 😃STORY: 50 year old Nebraska woman with Stage 4 Breast Cancer TNBC with bone metastases (diagnosed as Stage 4 since Dec.2022)In early March 2025 she started:Ivermectin 1mg/kg/dayMebendazole 1000mg/dayOncologist had her on CapecitabineResults after 3 months:Signatera went to zero and stayed at zeroPET/CT Showed improvement in multiple bone metastasesNo new metastases.A very straightforward case. You can see the patient has had multiple Signatera spikes of circulating tumor DNA until she started Ivermectin & Mebendazole and ever since then it dropped to zero and stayed at zero.Something her Oncologist couldn’t accomplish over past 3 years.